Clinical Trial

Accuracy of Interstitial Continuous Glucose Sensors in Neonates

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Low blood sugar in newborns is common and if prolonged or untreated may place them at increased risk for later learning and behavior challenges. Currently, we measure newborn glucose with at least four painful heel sticks, missing one in four episodes of low blood sugar. The goal of this observational study is to develop a less invasive approach to glucose monitoring, developed for newborns, that provides more frequent glucose measurements. We will also measure how a pregnant woman's health impacts newborn glucose, and how newborn glucose is linked to brain oxygen saturation and development.
Trial Details
NCT Number NCT07133906
Lead Sponsor Women and Infants Hospital of Rhode Island
Conditions Neonatal Hypoglycemia, Gestational Diabetes, Maternal Obesity Complicating Pregnancy, Small-for-gestational Age, Large-for-gestational Age
Enrollment 114 participants
Start Date 2025-09
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-21